177 related articles for article (PubMed ID: 7632075)
1. Severe erythema anulare centrifugum-like psoriatic drug eruption induced by terbinafine.
Wach F; Stolz W; Hein R; Landthaler M
Arch Dermatol; 1995 Aug; 131(8):960-1. PubMed ID: 7632075
[No Abstract] [Full Text] [Related]
2. Pustular psoriasiform eruption with leukocytosis associated with terbinafine.
Papa CA; Miller OF
J Am Acad Dermatol; 1998 Jul; 39(1):115-7. PubMed ID: 9674406
[No Abstract] [Full Text] [Related]
3. Erythema multiforme during cytomegalovirus infection and oral therapy with terbinafine: a virus-drug interaction.
Carducci M; Latini A; Acierno F; Amantea A; Capitanio B; Santucci B
J Eur Acad Dermatol Venereol; 2004 Mar; 18(2):201-3. PubMed ID: 15009306
[TBL] [Abstract][Full Text] [Related]
4. Terbinafine-induced subacute cutaneous lupus erythematosus.
Brooke R; Coulson IH; al-Dawoud A
Br J Dermatol; 1998 Dec; 139(6):1132-3. PubMed ID: 9990400
[No Abstract] [Full Text] [Related]
5. Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature.
Gupta AK; Lynde CW; Lauzon GJ; Mehlmauer MA; Braddock SW; Miller CA; Del Rosso JQ; Shear NH
Br J Dermatol; 1998 Mar; 138(3):529-32. PubMed ID: 9580815
[TBL] [Abstract][Full Text] [Related]
6. Exacerbation of systemic lupus erythematosus induced by terbinafine.
Holmes S; Kemmett D
Br J Dermatol; 1998 Dec; 139(6):1133. PubMed ID: 9990401
[No Abstract] [Full Text] [Related]
7. Terbinafine-induced lichenoid drug eruption.
Zheng Y; Zhang J; Chen H; Lai W; Maibach HI
Cutan Ocul Toxicol; 2017 Mar; 36(1):101-103. PubMed ID: 26938740
[TBL] [Abstract][Full Text] [Related]
8. Terbinafine induced pityriasis rosea-like eruption.
George A; Bhatia A; Kanish B; Williams A
Indian J Pharmacol; 2015; 47(6):680-1. PubMed ID: 26729964
[TBL] [Abstract][Full Text] [Related]
9. Acute generalized exanthematous pustulosis associated with oral terbinafine.
Hall AP; Tate B
Australas J Dermatol; 2000 Feb; 41(1):42-5. PubMed ID: 10715900
[TBL] [Abstract][Full Text] [Related]
10. Oral terbinafine and erythema multiforme.
Todd P; Halpern S; Munro DD
Clin Exp Dermatol; 1995 May; 20(3):247-8. PubMed ID: 7671425
[TBL] [Abstract][Full Text] [Related]
11. Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases.
Hill VA; Chow J; Cowley N; Marsden RA
Br J Dermatol; 2003 May; 148(5):1056. PubMed ID: 12786843
[No Abstract] [Full Text] [Related]
12. Pustular psoriasis induced by terbinafine : differential diagnosis from acute generalized exanthematous pustulosis.
Tokuyama Y; Senoh A; Setsu N; Iwatsuki K
Eur J Dermatol; 2008; 18(6):725-6. PubMed ID: 19049946
[No Abstract] [Full Text] [Related]
13. Oral terbinafine in the treatment of toenail onychomycosis: North American multicenter trial.
Drake LA; Shear NH; Arlette JP; Cloutier R; Danby FW; Elewski BE; Garnis-Jones S; Giroux JM; Gratton D; Gulliver W; Hull P; Jones HE; Journet M; Krol AL; Leyden JJ; Maddin SC; Ross JB; Savin RC; Scher RK; Sibbald GR; Tawfik NH; Zaias N; Tolpin M; Evans S; Birnbaum JE
J Am Acad Dermatol; 1997 Nov; 37(5 Pt 1):740-5. PubMed ID: 9366820
[TBL] [Abstract][Full Text] [Related]
14. Psoriatic Erythroderma Caused by Terbinafine: A Possible Pathogenetic Role for IL-23.
Oda T; Sawada Y; Yamaguchi T; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Okada E; Nakamura M
J Investig Allergol Clin Immunol; 2017; 27(1):63-64. PubMed ID: 28211348
[No Abstract] [Full Text] [Related]
15. [Generalized pruritic eruption during terbinafine treatment].
Amouri M; El Euch D; El Ouni B; Daoued O; Ouselati MH; Ferjani M; Dhahri AB
Presse Med; 2008 Dec; 37(12):1836-40. PubMed ID: 18656325
[No Abstract] [Full Text] [Related]
16. Hypersensitivity syndrome reaction to oral terbinafine.
Gupta AK; Porges AJ
Australas J Dermatol; 1998 Aug; 39(3):171-2. PubMed ID: 9737044
[TBL] [Abstract][Full Text] [Related]
17. Terbinafine-induced acute generalized exanthematous pustulosis.
Condon CA; Downs AM; Archer CB
Br J Dermatol; 1998 Apr; 138(4):709-10. PubMed ID: 9640388
[No Abstract] [Full Text] [Related]
18. Severe pustular psoriasis provoked by oral terbinafine.
Wilson NJ; Evans S
Br J Dermatol; 1998 Jul; 139(1):168. PubMed ID: 9764183
[No Abstract] [Full Text] [Related]
19. Spontaneous tolerance to terbinafine-induced lichenoid drug eruption.
Teraki Y; Shiohara T
Dermatology; 2004; 208(1):81-2. PubMed ID: 14730245
[No Abstract] [Full Text] [Related]
20. Oral corticosteroids did not prevent AGEP due to terbinafine.
Bajaj V; Simpson N
Acta Derm Venereol; 2006; 86(5):448-9. PubMed ID: 16955194
[No Abstract] [Full Text] [Related]
[Next] [New Search]
